ClinicalTrials.Veeva

Menu

In Vivo Proof-of-principle Study of Raman Spectroscopy in Trial Participants With Bladder Tumours

U

University Hospital Bispebjerg and Frederiksberg

Status and phase

Unknown
Phase 1

Conditions

Endoscopic Bladder Cancer Diagnosis With Raman

Treatments

Diagnostic Test: Raman Spectrometry

Study type

Interventional

Funder types

Other

Identifiers

NCT05124106
Clinical Protocol (MIB)

Details and patient eligibility

About

The purpose with this clinical investigation is to perform Raman spectroscopy inside the vivid bladder and to acquire Raman spectra of normal and tumour bladder tissue, and in a post-processing step to determine the grade of the tumor.

Full description

The purpose with this clinical investigation is to perform Raman spectroscopy inside the vivid bladder and to acquire Raman spectra of normal and tumour bladder tissue, and in a post-processing step to determine the grade of the bladder tumor.

The recordings and overall results will be compared to standard histo/cytopathological examination of urological tissue to achieve a clinical useful concordance between gold standard histo/cytopathological diagnosis and diagnostic information established by Raman.

The MIB RAMAN SYSTEM in combination with a Raman probe will be used in the operating theatre at Herlev/Copenhagen hospital urology department, where the rigid resectoscopes will be used while the trial participant is under general anesthesia. Each measurement takes about 1-5 seconds and the whole procedure with the fiber optic probes is expected to prolong the operation with 10-15 minutes.

Enrollment

30 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

After booking for surgery the trial participants will be informed orally about the study and written material will be given by a doctor or nurse form the study group. If the trial participant accept to enter the study, written informed consent will be obtained. The trial participant will be informed that they can withdraw the informed consent at any time and the treatment will be according to the guidelines of the department.

Exclusion criteria

  • Macroscopic hematuria
  • Pregnant or breast-feeding women
  • Expected poor compliance
  • Persons < 18 years
  • Persons who do not read or understand Danish
  • Dementia

Trial design

Primary purpose

Diagnostic

Allocation

Non-Randomized

Interventional model

Single Group Assignment

Masking

None (Open label)

30 participants in 1 patient group

Diagnostic ability of Raman spectrometry
Experimental group
Description:
Endoscopic Raman spectrometry during endoscopic bladder cancer surgery
Treatment:
Diagnostic Test: Raman Spectrometry

Trial contacts and locations

1

Loading...

Central trial contact

Karin Mogensen, MD; Gregers G Hermann, DM Sc

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems